The 2025 ESC Guidelines integrate myocarditis and pericarditis into the unified concept of inflammatory myopericardial syndrome (IMPS), acknowledging their overlapping aetiologies.
The 2025 ESC guidelines provide a unified framework for myocarditis and pericarditis, introducing the concept of inflammatory myopericardial syndrome (IMPS).
The 2025 European Society of Cardiology (ESC) Guidelines on Myocarditis and Pericarditis represent the first unified framework addressing both conditions under a single guideline. For the first time, myocarditis and pericarditis are integrated into the concept of inflammatory myopericardial syndrome (IMPS), acknowledging their overlapping aetiologies and forms of these contiguous cardiac structures.(1) This document provides a critical summary of the main novelties, focusing on implications for clinical practice.
Imazio et al. (Mon,) conducted a review in Myocarditis and Pericarditis. 2025 ESC Guidelines on Myocarditis and Pericarditis was evaluated. The 2025 ESC Guidelines integrate myocarditis and pericarditis into the unified concept of inflammatory myopericardial syndrome (IMPS), acknowledging their overlapping aetiologies.